Loading chat...
MS HB1434
Bill
Status
2/5/2019
Primary Sponsor
Stephen Holland
Click for details
AI Summary
-
Requires prescribers to discuss with patients the risks of Schedule II controlled substances and opioid drugs before issuing the initial prescription for acute or chronic pain treatment.
-
Mandates a second discussion about risks and alternatives occur before issuing the third prescription in a course of treatment.
-
Specifies required discussion topics including addiction and overdose risks, dangers of mixing opioids with alcohol and other central nervous system depressants, reasons for the prescription, and available alternative treatments.
-
Requires prescribers to document in the patient's medical record that the patient or parent/guardian (for minors) discussed risks of dependence and alternative treatments.
-
Takes effect July 1, 2019.
Legislative Description
Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.
Last Action
Died In Committee
2/5/2019